Cervical Dysplasia sales were dominated by North America in 2019, with a revenue share of 40.4%. Throughout the projection period, it is anticipated that the region would keep its position. The region's Cervical Dysplasia Market is expected to be driven by factors including technological advancements, an increase in the prevalence of various associated diseases, rising awareness and screening programmes, and supportive initiatives by public and private organisations to increase the adoption of HPV testing. Additionally, a direct-to-consumer product, an HPV testing kit, was released by California-based telemedicine business Nurx in December 2018.
Read More- https://cmi-latestreportorientedblogs.blogspot.com/2022/11/cervical-dysplasia-market-emerging.html
